Showing results (301-310 of 983) with videos related to
Sort By:
Pageof 99
Journal of Cardiac Failure|January 1, 2013
A randomized controlled pilot study of outcomes of strict allowance of fluid therapy in hyponatremic heart failure (SALT-HF)Nancy M Albert, Benjamin Nutter, Jennifer Forney, et al.Pharmacotherapy|January 1, 1983
A double-blind clinical trial of mianserin versus amitriptyline: differentiation by adverse symptomatologyW Guy, J M McEvoy, T A Ban, et al.Journal of Cardiac Failure|September 13, 2025
Evolving Natural History of Left Ventricular Ejection Fraction Recovery and Relapse in Heart Failure With Reduced Ejection FractionNandan Kodur, Paul Gunsalus, Alex Milinovich, et al.European Journal of Heart Failure|February 20, 2025
Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosisJoshua Longinow, Saeid Mirzai, Po-Hao Chen, et al.Heart Failure Reviews|July 29, 2024
Management of patients with heart failure and chronic kidney diseaseLingling Wu, Mario Rodriguez, Karim El Hachem, et al.The Journal of Clinical Psychiatry|January 1, 1983
Somatic symptoms in depression and antidepressantsR J Mathew, M L Weinman, R Thapar, et al.International Pharmacopsychiatry|January 1, 1980
Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical studyW M Petrie, J P McEvoy, W H Wilson, et al.International Pharmacopsychiatry|January 1, 1982
Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical studyW M Petrie, T A Ban, W H Wilson, et al.Journal of Cardiac Failure|September 2, 2014
Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failureJustin L Grodin, Muhammad Hammadah, Yiying Fan, et al.The American Journal of Medicine|August 30, 2008
Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic optionsAshish Aneja, W H Wilson Tang, Sameer Bansilal, et al.Pageof 99